To ensure that vaccines provide strong and lasting immunization, it is often necessary to supplement the actual vaccine (antigen) with additives that stimulate the immune system: adjuvants. Today, only a few substances...
The Federal Ministry of Education and Research (BMBF) is funding the establishment of a German-Ukrainian core of excellence to help discover new anti-infectives and make them available for medical purposes. The core of...
Improving health care and strengthening personalized medicine: A new research center for Artificial Intelligence (AI) and causal methods in medicine (CAIMed - Lower Saxony Center for Artificial Intelligence and Causal...
The list of “Highly-cited researchers” is published annually by Clarivate Analytics to honor scientists who have made a particularly significant impact in their fields. Five heads of department at the Helmholtz Centre...
Sustainable and environmentally friendly production processes are playing an increasingly important role in almost all branches of industry. The production of active pharmaceutical ingredients in particular involves the...
Professor Thomas Pietschmann, Scientific Co-Director of the Helmholtz Centre for Infection Research (HZI), Professor of Experimental Virology at Hannover Medical School (MHH) and virologist at TWINCORE - Centre for...
In the context of the tenure negotiations for Drug Bioinformatics Professor Olga Kalinina, the Klaus Faber Foundation is providing €100,000 to the "bioINFpro" project, thereby enabling her long-term stay at the...
Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared. Researchers at...
Researchers from the Department of Drug Design and Optimisation have developed molecules that can drastically reduce the pathogenic effects of the hospital germ Pseudomonas aeruginosa. In this interview, the authors Dr....
